GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Other Stockholders Equity

Curocell (XKRX:372320) Other Stockholders Equity : ₩7,236.49 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Other Stockholders Equity?

Curocell's Other Stockholders Equity for the quarter that ended in Jun. 2023 was ₩7,236.49 Mil.

Curocell's quarterly Other Stockholders Equity increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩8,014.42 Mil) but then declined from Dec. 2022 (₩8,014.42 Mil) to Jun. 2023 (₩7,236.49 Mil).

Curocell's annual Other Stockholders Equity increased from Dec. 2021 (₩4,774.21 Mil) to Dec. 2022 (₩8,014.42 Mil) but then declined from Dec. 2022 (₩8,014.42 Mil) to Dec. 2023 (₩7,096.65 Mil).


Curocell Other Stockholders Equity Historical Data

The historical data trend for Curocell's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Other Stockholders Equity Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
79.24 1,997.98 4,774.21 8,014.42 7,096.65

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity - 8,014.42 7,236.49 7,096.65

Curocell Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Curocell Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Curocell's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines